ImmunityBio Company
ImmunityBio is an offshoot of Soon-Shiong's NantWorks conglomerate, developing molecular-level cell-based treatments for diseases.
Technology:
Atrificial Vectors and Immune Cells, Cell therapy
Industry:
Deep Diagnostics, Public
Headquarters:
Culver City, California, United States
Founded Date:
2014-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
2
Total Funding:
389656035
Estimated Revenue:
$50M to $100M
Last Funding Date:
2023-02-15
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership